Protecting Innovation and Controlling Trade Agreement Changes, Especially for Vaccines.
This act aims to protect American innovation, particularly in vaccines, by limiting modifications to trade agreements without Congressional consent. It introduces new rules for public consultation and impact analysis on the economy and national security before any changes to trade agreements, including intellectual property. This ensures that trade and innovation decisions are made with full consideration of their consequences for citizens and the economy.
Key points
Requires Congressional approval for any changes to trade agreements that could affect US rights or citizens, especially concerning China and Russia.
Mandates detailed analyses of public health, economic, and national security impacts before any potential waiver of intellectual property protections for COVID-19 vaccines.
Grants citizens and Congress greater influence over trade agreement decisions through mandatory public consultations and reports prior to negotiations.
Expired
Citizen Poll